Agriculture & Natural Solutions Acquisition Corporation Class A Ordinary Shares (ANSC)
USD 10.45
(-0.1%)
USD 10.45
(-0.1%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | - | - | - |
| Cost of Revenue | - | - | - |
| Gross Profit | - | - | - |
| Operating Expenses | 1.15 Million | 1225.00 | 8389.00 |
| Selling, General and Administrative Expenses | 1.15 Million | 1225.00 | 8389.00 |
| Research and Development Expenses | - | - | - |
| Other Expenses | - | - | - |
| Cost and Expenses | 1.15 Million | 1225.00 | 8389.00 |
| Operating Income | -1.15 Million | -1220.00 | -8390.00 |
| Interest Expense | - | - | - |
| Income Tax Expense | - | -1225.00 | -11.18 Thousand |
| Earnings before Tax | 1.3 Million | -1225.00 | -8389.00 |
| Net Income | 1.3 Million | -1225.00 | -8389.00 |
| Earnings Per Share Basic | 0.17 | - | -0.00 |
| Earnings Per Share Diluted | 0.11 | - | -0.00 |
| Weighted Average Shares Outstanding | 7.65 Million | 43.12 Million | 43.12 Million |
| Weighted Average Shares Outstanding (Diluted) | 12.41 Million | 43.12 Million | 43.12 Million |
| Gross Margin | - | - | - |
| EBIT Margin | - | - | - |
| Profit Margin | - | - | - |
| EBITDA | - | - | - |
| Earnings Before Tax Margin | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 2.51 Million | 551.25 Thousand | 1.15 Million | 1.15 Million | - | - |
| Selling, General and Administrative Expenses | 2.51 Million | 551.25 Thousand | - | 1.15 Million | - | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 2.51 Million | 551.25 Thousand | 1.15 Million | 1.15 Million | - | - |
| Operating Income | -2.51 Million | -551.26 Thousand | -1.15 Million | -1.15 Million | - | - |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -2.51 Million | -551.25 Thousand | -1.15 Million | -1.15 Million | - | - |
| Earnings before Tax | 2.24 Million | 4.13 Million | 1.3 Million | 1.3 Million | - | - |
| Net Income | 2.24 Million | 4.13 Million | 1.3 Million | 1.3 Million | - | - |
| Earnings Per Share Basic | 0.05 | 0.10 | - | 0.03 | - | - |
| Earnings Per Share Diluted | 0.05 | 0.10 | - | 0.03 | - | - |
| Weighted Average Shares Outstanding | 43.12 Million | 43.12 Million | 43.12 Million | 43.12 Million | 43.12 Million | 43.12 Million |
| Weighted Average Shares Outstanding (Diluted) | 43.12 Million | 43.12 Million | 43.12 Million | 43.12 Million | 43.12 Million | 43.12 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -2.51 Million | -551.26 Thousand | - | -1.15 Million | - | - |
| Earnings Before Tax Margin | - | - | - | - | - | - |
SRBT
0571
INTUCH
ITJTY
CRTO
BIOGY